Review article · 2026 · Open access

Granulocyte heterogeneity in immune-mediated and inflammatory diseases: insights from single-cell transcriptomic analyses

Hiroshi Shimagami, Atsushi Kumanogoh, Masayuki Nishide

International Immunology, 38(10), 585–593 · Published 26 May 2026 · DOI 10.1093/intimm/dxag026

Open full textCite this paper

In brief

“Granulocyte heterogeneity in immune-mediated and inflammatory diseases: insights from single-cell transcriptomic analyses” is a 2026 review article by Hiroshi Shimagami and 2 co-authors, published in International Immunology. OpenAlex counts 0 citations as of 19 November 2026. It is open access under a CC BY licence: the full text is free to read at International Immunology.

Citations
0
References
64
Authors
3

Abstract

Neutrophils and eosinophils have long been regarded as terminal effectors of innate immunity. Technical advances in single-cell RNA sequencing define transcriptome-based granulocyte subsets beyond classical density- and surface marker-based classifications. These approaches reveal substantial heterogeneity in granulocyte differentiation states, activation programs, and tissue adaptation across human diseases. In microscopic polyangiitis, type II interferon (IFN) pathways shape a pathogenic neutrophil activation state, and serum IFNγ levels at disease onset may serve as a potential biomarker for subsequent relapse. In infectious diseases, including coronavirus disease 2019 (COVID-19) and sepsis, the expansion of immunosuppressive ARG1- and IL1R2-expressing neutrophils is reported in severe disease and may reflect altered immune responses. MMP9-high neutrophils are enriched in cardiovascular disorders and may be linked to thrombosis and ischemic injury. In allergic diseases, spatial and single-cell analyses identify tissue-specific eosinophil states and their interactions with epithelial and macrophage compartments, highlighting context-dependent eosinophil activation within inflamed tissues. Despite emerging evidence for disease-associated granulocyte heterogeneity, whether these populations causally contribute to disease pathophysiology remains largely unclear. Experimentally validated functions and clinically applicable surrogate markers, such as surface markers or circulating proteins, are still needed. This review summarizes recent advances and current limitations in understanding granulocyte heterogeneity across immune-mediated and inflammatory diseases and discusses how integrative single-cell approaches may support the development of clinically relevant biomarkers and targeted therapeutic strategies.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Shimagami, H., Kumanogoh, A., & Nishide, M. (2026). Granulocyte heterogeneity in immune-mediated and inflammatory diseases: insights from single-cell transcriptomic analyses. International Immunology, 38(10), 585–593. https://doi.org/10.1093/intimm/dxag026

MLA 9

Shimagami, Hiroshi, et al. “Granulocyte heterogeneity in immune-mediated and inflammatory diseases: insights from single-cell transcriptomic analyses.” International Immunology, vol. 38, no. 10, 2026, pp. 585–593. https://doi.org/10.1093/intimm/dxag026.

Chicago

Shimagami, Hiroshi, Atsushi Kumanogoh, and Masayuki Nishide. 2026. “Granulocyte heterogeneity in immune-mediated and inflammatory diseases: insights from single-cell transcriptomic analyses.” International Immunology 38 (10): 585–593. https://doi.org/10.1093/intimm/dxag026.

Harvard

Shimagami, H., Kumanogoh, A. and Nishide, M. (2026) ‘Granulocyte heterogeneity in immune-mediated and inflammatory diseases: insights from single-cell transcriptomic analyses’, International Immunology, 38(10), pp. 585–593. doi:10.1093/intimm/dxag026.

IEEE

H. Shimagami, A. Kumanogoh, and M. Nishide, “Granulocyte heterogeneity in immune-mediated and inflammatory diseases: insights from single-cell transcriptomic analyses,” International Immunology, vol. 38, no. 10, pp. 585–593, 2026, doi: 10.1093/intimm/dxag026.

BibTeX

@article{shimagami2026granulocyte,
  title     = {{Granulocyte heterogeneity in immune-mediated and inflammatory diseases: insights from single-cell transcriptomic analyses}},
  author    = {Shimagami, Hiroshi and Kumanogoh, Atsushi and Nishide, Masayuki},
  journal   = {International Immunology},
  year      = {2026},
  volume    = {38},
  number    = {10},
  pages     = {585--593},
  doi       = {10.1093/intimm/dxag026},
  url       = {https://doi.org/10.1093/intimm/dxag026}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics

  • neutrophils
  • eosinophils
  • single-cell transcriptomics
  • microscopic polyangiitis
  • interferon-gamma
  • Arg1
  • IL1R2
  • COVID-19 pandemic

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Shimagami, H., Kumanogoh, A., & Nishide, M. (2026). Granulocyte heterogeneity in immune-mediated and inflammatory diseases: insights from single-cell transcriptomic analyses. International Immunology, 38(10), 585–593. https://doi.org/10.1093/intimm/dxag026

How many times has this paper been cited?

0 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at International Immunology: sign in and open the full text from this page.

Who wrote this paper?

Hiroshi Shimagami, Atsushi Kumanogoh, Masayuki Nishide.

What is the DOI of this paper?

10.1093/intimm/dxag026, permanently at https://doi.org/10.1093/intimm/dxag026. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.